Cargando…
Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines
Glioblastoma is a fatal primary malignant brain tumor, and the 5-year survival rate of treated glioblastoma patients still remains <5%. Considering the sustained development of metastasis, tumor recurrence, and drug resistance, there is an urgent need for the novel therapeutic approaches to comba...
Autores principales: | Yuan, Bo, Xu, Kang, Shimada, Ryota, Li, JingZhe, Hayashi, Hideki, Okazaki, Mari, Takagi, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009626/ https://www.ncbi.nlm.nih.gov/pubmed/33796463 http://dx.doi.org/10.3389/fonc.2021.628914 |
Ejemplares similares
-
Corrigendum: Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines
por: Yuan, Bo, et al.
Publicado: (2021) -
JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine via Modulating Cell Cycle Progression in Human Breast Cancer Cells
por: Yu, Bowen, et al.
Publicado: (2020) -
Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
por: Yuan, Bo, et al.
Publicado: (2018) -
Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87
por: Han, Lingyu, et al.
Publicado: (2018) -
Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells
por: Zhang, Yu, et al.
Publicado: (2021)